MRUSMerus N.V.

MRUS Stock Price, Valuation & Chart | Merus N.V.

Compare

$90.000+0.00 (+0.00%)

At close · 02 Jan 2026, 02:30 pm

Sector: Healthcare Industry: Biotechnology MRUS intrinsic value MRUS calculated fair value vs price

Overview Financials Dividends Ratios

MRUS Historical price chart

MRUS Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization6.83B

PE Ratio-17.05

EPS-5.28

Trading Volume2.72M

Today's High/Low90.0/90.0

Dividend Yield0.00

52 Week High/Low97.14/33.19

Shares Outstanding75.84M

MRUS Financial Statement

MRUS Analyst ratings

MRUS Analysis & performance metrics

MRUS Company profile

Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody…

Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 clinical trials for the treatment of…

MRUS Management team

Name

Position

Fabian Zohren M.D., Ph.D.

Chief Medical Officer

Cecilia Anna Wilhelmina Geuijen Ph.D.

Chief Scientific Officer & Senior Vice President

Hennie Hoogenboom

Co-Founder and Scientific Advisor

Sven Ante Lundberg M.D.CEO

Chief Executive Officer, President & Executive Director

Gregory D. PerryCFO

Chief Financial Officer

Audrey Bergan

Chief People Officer

Peter B. Silverman J.D.COO

EVice President, Company Secretary, Chief Operating Officer, General Counsel, Chief Intellectual Property Officer & Head of US Legal

Harry Shuman

Chief Accounting Officer

Name

Position

Fabian Zohren M.D., Ph.D.

Chief Medical Officer

Cecilia Anna Wilhelmina Geuijen Ph.D.

Chief Scientific Officer & Senior Vice President

Hennie Hoogenboom

Co-Founder and Scientific Advisor

Sven Ante Lundberg M.D.CEO

Chief Executive Officer, President & Executive Director

Gregory D. PerryCFO

Chief Financial Officer

Audrey Bergan

Chief People Officer

Peter B. Silverman J.D.COO

EVice President, Company Secretary, Chief Operating Officer, General Counsel, Chief Intellectual Property Officer & Head of US Legal

Harry Shuman

Chief Accounting Officer

Management Team

Fabian Zohren M.D., Ph.D.

Chief Medical Officer

Cecilia Anna Wilhelmina Geuijen Ph.D.

Chief Scientific Officer & Senior Vice President

Hennie Hoogenboom

Co-Founder and Scientific Advisor

Sven Ante Lundberg M.D.CEO

Chief Executive Officer, President & Executive Director

Gregory D. PerryCFO

Chief Financial Officer

Audrey Bergan

Chief People Officer

Peter B. Silverman J.D.COO

EVice President, Company Secretary, Chief Operating Officer, General Counsel, Chief Intellectual Property Officer & Head of US Legal

Harry Shuman

Chief Accounting Officer

Management

Fabian Zohren M.D., Ph.D.

Chief Medical Officer

Cecilia Anna Wilhelmina Geuijen Ph.D.

Chief Scientific Officer & Senior Vice President

Hennie Hoogenboom

Co-Founder and Scientific Advisor

Sven Ante Lundberg M.D.CEO

Chief Executive Officer, President & Executive Director

Gregory D. PerryCFO

Chief Financial Officer

Audrey Bergan

Chief People Officer

Peter B. Silverman J.D.COO

EVice President, Company Secretary, Chief Operating Officer, General Counsel, Chief Intellectual Property Officer & Head of US Legal

Harry Shuman

Chief Accounting Officer

Total 8 executives

MRUS Frequently asked questions

What is Merus N.V. (MRUS) Stock Price?

Current stock price of Merus N.V. (MRUS) stock is $90.000. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Merus N.V. (MRUS) stock is 2.72M.

Last updated at 02 Jan 2026, 02:30 pm.

Why is the Merus N.V. (MRUS) stock price going up or down today?

The stock price of Merus N.V. (MRUS) can change with earnings, company news, and overall market sentiment. Merus N.V. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Merus N.V. stock expensive at its current price?

Whether Merus N.V. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MRUS on this page is -17.05. EPS on this page is -5.28. Compare those figures with peers and growth expectations before deciding if the current Merus N.V. price is justified.

How has the stock price of Merus N.V. (MRUS) performed historically?

Historical performance for Merus N.V. (MRUS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MRUS reacted to past earnings and market events.

Should I buy Merus N.V. (MRUS) stock, at this price?

Buying Merus N.V. (MRUS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.